Position in LEGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,063,299
+$1,808,909 QoQ
Shares Held
175,322
-2.5% QoQ
Ownership
0.090%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#55
of 217 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LEGN Over Time
Shares Held
Position Value (USD)
Derivatives in LEGN
reported options exposure · as of Mar 31, 2024CallValue
$796,478
CallShares
14,200
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BARCLAYS PLC holds $1,706,205,173 across 455 Biotechnology names. LEGN ranks #40 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
733,274 | $364,239,192 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,192 | $159,745,957 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
1,603,136 | $127,112,653 | |
| 4 | ARGX |
Argenx SE
|
134,427 | $124,717,337 | |
| 5 | MRNA |
Moderna, Inc.
|
1,035,126 | $72,489,872 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
714,423 | $53,210,224 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
957,848 | $52,624,168 | |
| 8 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
431,753 | $42,087,281 |
All Filings in LEGN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,063,299 | 175,322 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $3,254,390 | 179,900 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $5,952,845 | 273,820 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,643,757 | 81,072 | Shares | Sole | 2026-03-31 | |
| 2025-06-30 | $6,804,532 | 191,731 | Shares | Sole | 2026-02-27 | |
| 2025-03-31 | $7,955,226 | 234,460 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $4,118,619 | 126,571 | Shares | Sole | 2026-03-19 | |
| 2024-09-30 | $7,813,854 | 160,350 | Shares | Sole | 2026-03-31 | |
| 2024-06-30 | $8,681,415 | 196,013 | Shares | Sole | 2026-03-23 | |
| 2024-03-31 | $11,582,977 | 206,507 | Shares | Sole | 2026-03-24 | |
| 2024-03-31 | $796,478 | 14,200 | Call | Sole | 2026-03-24 | |
| 2023-12-31 | $11,274,955 | 187,385 | Shares | Sole | 2026-03-24 | |
| 2023-09-30 | $18,881,083 | 281,094 | Shares | Sole | 2026-03-26 | |
| 2023-06-30 | $5,780,365 | 83,737 | Shares | Sole | 2026-03-27 | |
| 2023-03-31 | $10,779,002 | 223,538 | Shares | Sole | 2026-03-30 | |
| 2022-12-31 | $1,497,600 | 30,000 | Call | Sole | 2026-03-30 | |
| 2022-12-31 | $23,574,919 | 472,254 | Shares | Sole | 2026-03-30 | |
| 2022-12-31 | $49,920 | 1,000 | Put | Sole | 2026-03-30 | |
| 2022-09-30 | $12,289,449 | 301,212 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $16,110,160 | 292,912 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $8,915,145 | 245,326 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||